Liquid formulation of decitabine and use of the same

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7068 (2006.01) A61K 9/14 (2006.01) A61K 31/7072 (2006.01) A61K 47/10 (2006.01)

Patent

CA 2488108

Pharmaceutical formulations, kits and vessels are provided for delivering decitabine to a patient suffering from a disease in need of treatment with decitabine. The pharmaceutical formulation comprises decitabine solvated in a non-aqueous solvent that comprises glycerin, propylene glycol, polyethylene glycol, or combinations. Such formulations are more chemically stable than conventional liquid formulations of decitabine containing more than 40% water in volume. The pharmaceutical formulations can be used for any disease that is sensitive to the treatment with decitabine, such as hematological disorders and cancer.

L'invention porte sur une préparation pharmaceutique et des trousses et des récipients associés servant à administrer de la décitabine à un patient le nécessitant. Ladite préparation comprend de la décibatine dissoute dans un solvant non aqueux comprenant de la glycérine, du propylène glycol, du polyéthylène glycol, ou leur combinaison combinaisons. Une telle préparation est plus stable chimiquement que les préparations liquides usuelles de décitabine contenant plus de 40 % d'eau en volume. Une telle préparation peut traiter toute maladie sensible à un traitement par la décitabine, dont les troubles hématologiques et le cancer.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Liquid formulation of decitabine and use of the same does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Liquid formulation of decitabine and use of the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Liquid formulation of decitabine and use of the same will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2007132

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.